BaxΔ2 is a novel bax isoform unique to microsatellite unstable tumors

Journal of Biological Chemistry

Volumn 287, Issue 41, 2012, Pages 34722-34729

  Haferkamp, Bonnie ^a   Zhang, Honghong ^a   Lin, Yuting ^a   Yeap, Xinyi ^a   Bunce, Alex ^a   Sharpe, Juanita ^b   Xiang, Jialing ^a  

^a Illinois Institute of Technology   (United States)

^b CHICAGO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRIAMYCIN; ALTERNATIVE SPLICING; BCL-2 FAMILY PROTEINS; CELL LINES; CHEMOTHERAPEUTIC AGENTS; ISOFORMS; MICRO SATELLITE; MICROSATELLITE INSTABILITY; TUMOR CELLS; TUMOR DEVELOPMENT; TUMOR SUPPRESSORS;

CELL CULTURE; CELL DEATH; DNA SEQUENCES;

TUMORS;

DOXORUBICIN; PROTEIN BAX; PROTEIN BAX DELTA 2; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CARCINOGENESIS; COLON CANCER; CONTROLLED STUDY; CYTOTOXICITY; EXON; IMMUNOFLUORESCENCE; MICROSATELLITE INSTABILITY; MITOCHONDRION; NEOPLASM; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION;

ALTERNATIVE SPLICING; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BASE SEQUENCE; BCL-2-ASSOCIATED X PROTEIN; CELL LINE, TUMOR; DOXORUBICIN; EXONS; HUMANS; MICE; MICE, KNOCKOUT; MICROSATELLITE INSTABILITY; MOLECULAR SEQUENCE DATA; NEOPLASMS; PROTEIN ISOFORMS;

EID: 84867264063     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.374785     Document Type: Article

References (53)

1. Habraken, Y., Sung, P., Prakash, L., and Prakash, S. (1996) Binding of insertion/deletion DNA mismatches by the heterodimer of yeast mismatch repair proteins MSH2 and MSH3. Curr. Biol. 6, 1185-1187 (Pubitemid 26368753)
2. Elliott, B., and Jasin, M. (2001) Repair of double-strand breaks by homologous recombination in mismatch repair-defective mammalian cells. Mol. Cell. Biol. 21, 2671-2682 (Pubitemid 32244912)
3. Duval, A., and Hamelin, R. (2002) Mutations at coding repeat sequences in mismatch repair-deficient human cancers. Toward a new concept of target genes for instability. Cancer Res. 62, 2447-2454 (Pubitemid 34462716)
4. Falchetti, M., Saieva, C., Lupi, R., Masala, G., Rizzolo, P., Zanna, I., Ceccarelli, K., Sera, F., Mariani-Costantini, R., Nesi, G., Palli, D., and Ottini, L. (2008) Gastric cancer with high-level microsatellite instability. Target gene mutations, clinicopathologic features, and long-term survival. Hum. Pathol. 39, 925-932
5. Goel, A., Arnold, C. N., Niedzwiecki, D., Chang, D. K., Ricciardiello, L., Carethers, J. M., Dowell, J. M., Wasserman, L., Compton, C., Mayer, R. J., Bertagnolli, M. M., and Boland, C. R. (2003) Characterization of sporadic colon cancer by patterns of genomic instability. Cancer Res. 63, 1608-1614 (Pubitemid 36373651)
6. Kuismanen, S. A., Moisio, A. L., Schweizer, P., Truninger, K., Salovaara, R., Arola, J., Butzow, R., Jiricny, J., Nyström-Lahti, M., and Peltomäki, P. (2002) Endometrial and colorectal tumors from patients with hereditary nonpolyposis colon cancer display different patterns of microsatellite instability. Am. J. Pathol. 160, 1953-1958 (Pubitemid 34663387)
7. Shima, K., Morikawa, T., Yamauchi, M., Kuchiba, A., Imamura, Y., Liao, X., Meyerhardt, J. A., Fuchs, C. S., and Ogino, S. (2011) TGFBR2 and BAX mononucleotide tract mutations, microsatellite instability, and prognosis in 1072 colorectal cancers. PLoS One 6, e25062
8. El-Bchiri, J., Buhard, O., Penard-Lacronique, V., Thomas, G., Hamelin, R., and Duval, A. (2005) Differential nonsense mediated decay of mutated mRNAs in mismatch repair deficient colorectal cancers. Hum. Mol. Genet.14, 2435-2442 (Pubitemid 41418005)
9. Zhang, L., Yu, J., Park, B. H., Kinzler, K. W., and Vogelstein, B. (2000) Role of BAX in the apoptotic response to anticancer agents. Science 290, 989-992
10. Jeong, S. H., Lee, H. W., Han, J. H., Kang, S. Y., Choi, J. H., Jung, Y. M., Choi, H., Oh, Y. T., Park, K. J., Hwang, S. C., Sheen, S. S., Oh, Y. J., Kim, J. H., and Lim, H. Y. (2008) Low expression of Bax predicts poor prognosis in resected non-small cell lung cancer patients with non-squamous histology. Jpn J. Clin. Oncol. 38, 661-669
11. Krajewski, S., Blomqvist, C., Franssila, K., Krajewska, M., Wasenius, V. M., Niskanen, E., Nordling, S., and Reed, J. C. (1995) Reduced expression of proapoptotic gene BAX is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Res. 55, 4471-4478
12. Olejniczak, S. H., Hernandez-Ilizaliturri, F. J., Clements, J. L., and Czuczman, M. S. (2008) Acquired resistance to rituximab is associated with chemotherapy resistance resulting from decreased Bax and Bak expression. Clin. Cancer Res. 14, 1550-1560 (Pubitemid 351413940)
13. Zhou, M., Demo, S. D., McClure, T. N., Crea, R., and Bitler, C. M. (1998) A novel splice variant of the cell death-promoting protein BAX. J. Biol. Chem. 273, 11930-11936 (Pubitemid 28272102)
14. Thomas, A. L., Price, C., Martin, S. G., Carmichael, J., and Murray, J. C. (1999) Identification of two novel mRNA splice variants of bax. Cell Death Differ 6, 97-98 (Pubitemid 29082296)
15. Schmitt, E., Paquet, C., Beauchemin, M., Dever-Bertrand, J., and Bertrand, R. (2000) Characterization of Bax-σ, a cell death-inducing isoform of Bax. Biochem. Biophys. Res. Commun. 270, 868-879 (Pubitemid 30444799)
16. Oltvai, Z. N., Milliman, C. L., and Korsmeyer, S. J. (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74, 609-619 (Pubitemid 23259742)
17. Fu, N. Y., Sukumaran, S. K., Kerk, S. Y., and Yu, V. C. (2009) Baxbeta. A constitutively active human Bax isoform that is under tight regulatory control by the proteasomal degradation mechanism. Mol. Cell 33, 15-29
18. Cartron, P. F., Oliver, L., Martin, S., Moreau, C., LeCabellec, M. T., Jezequel, P., Meflah, K., and Vallette, F. M. (2002) The expression of a new variant of the pro-apoptotic molecule Bax, Baxpsi, is correlated with an increased survival of glioblastoma multiforme patients. Hum. Mol. Genet. 11, 675-687 (Pubitemid 34285139)
19. Apte, S. S., Mattei, M. G., and Olsen, B. R. (1995) Mapping of the human BAX gene to chromosome 19q13.3-q13.4 and isolation of a novel alternatively spliced transcript, BAXΔ. Genomics 26, 592-594
20. Yin, X. M., Oltvai, Z. N., and Korsmeyer, S. J. (1994) BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 369, 321-323 (Pubitemid 24159542)
21. Sedlak, T. W., Oltvai, Z. N., Yang, E., Wang, K., Boise, L. H., Thompson, C. B., and Korsmeyer, S. J. (1995) Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proc. Natl. Acad. Sci. U.S.A. 92, 7834-7838
22. Zha, H., Aimé-Sempé, C., Sato, T., and Reed, J. C. (1996) Proapoptotic protein Bax heterodimerizes with Bcl-2 and homodimerizes with Bax via a novel domain (BH3) distinct from BH1 and BH2. J. Biol. Chem. 271, 7440-7444 (Pubitemid 26107015)
23. Jürgensmeier, J. M., Xie, Z., Deveraux, Q., Ellerby, L., Bredesen, D., and Reed, J. C. (1998) Bax directly induces release of cytochrome c from isolated mitochondria. Proc. Natl. Acad. Sci. U.S.A. 95, 4997-5002 (Pubitemid 28208539)
24. Wei, M. C., Zong, W. X., Cheng, E. H., Lindsten, T., Panoutsakopoulou, V., Ross, A. J., Roth, K. A., MacGregor, G. R., Thompson, C. B., and Korsmeyer, S. J. (2001) Proapoptotic BAX and BAK. A requisite gateway to mitochondrial dysfunction and death. Science 292, 727-730 (Pubitemid 32385543)
25. Annis, M. G., Soucie, E. L., Dlugosz, P. J., Cruz-Aguado, J. A., Penn, L. Z., Leber, B., and Andrews, D. W. (2005) Bax forms multispanning monomers that oligomerize to permeabilize membranes during apoptosis. EMBO J. 24, 2096-2103 (Pubitemid 40961794)
26. Korsmeyer, S. J. (1999) BCL-2 gene family and the regulation of programmed cell death. Cancer Res. 59, 1693s-1700s
27. Cartron, P. F., Priault, M., Oliver, L., Meflah, K., Manon, S., and Vallette, F. M. (2003) The N-terminal end of Bax contains a mitochondrial- targeting signal. J. Biol. Chem. 278, 11633-11641 (Pubitemid 36792725)
28. Rampino, N., Yamamoto, H., Ionov, Y., Li, Y., Sawai, H., Reed, J. C., and Perucho, M. (1997) Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 275, 967-969 (Pubitemid 27087710)
29. Schwartz, S., Jr., Yamamoto, H., Navarro, M., Maestro, M., Reventós, J., and Perucho, M. (1999) Frameshift mutations at mononucleotide repeats in caspase-5 and other target genes in endometrial and gastrointestinal cancer of the microsatellite mutator phenotype. Cancer Res. 59, 2995-3002 (Pubitemid 29283143)
30. Kawaguchi, M., Banno, K., Yanokura, M., Kobayashi, Y., Kishimi, A., Ogawa, S., Kisu, I., Nomura, H., Hirasawa, A., Susumu, N., and Aoki, D. (2009) Analysis of candidate target genes for mononucleotide repeat mutation in microsatellite instability-high (MSI-H) endometrial cancer. Int. J. Oncol. 35, 977-982
31. Hussain, A. R., Ahmed, M., Al-Jomah, N. A., Khan, A. S., Manogaran, P., Sultana, M., Abubaker, J., Platanias, L. C., Al-Kuraya, K. S., and Uddin, S. (2008) Curcumin suppresses constitutive activation of nuclear factor-κB and requires functional Bax to induce apoptosis in Burkitt's lymphoma cell lines. Mol. Cancer Ther. 7, 3318-3329
32. Tamm, I., Schumacher, A., Karawajew, L., Ruppert, V., Arnold, W., Nüssler, A. K., Neuhaus, P., Dörken, B., and Wolff, G. (2002) Adenovirus-mediated gene transfer of P16INK4/CDKN2 into Bax-negative colon cancer cells induces apoptosis and tumor regression in vivo. Cancer Gene Ther. 9, 641-650 (Pubitemid 34847571)
33. Williams, D. S., Bird, M. J., Jorissen, R. N., Yu, Y. L., Walker, F., Zhang, H. H., Nice, E. C., and Burgess, A. W. (2010) Nonsense mediated decay resistant mutations are a source of expressed mutant proteins in colon cancer cell lines with microsatellite instability. PLoS One 5, e16012
34. Fallik, D., Borrini, F., Boige, V., Viguier, J., Jacob, S., Miquel, C., Sabourin, J. C., Ducreux, M., and Praz, F. (2003) Microsatellite instability is a predictive factor of the tumor response to irinotecan in patients with advanced colorectal cancer. Cancer Res. 63, 5738-5744 (Pubitemid 37187470)
35. Jung, B., Smith, E. J., Doctolero, R. T., Gervaz, P., Alonso, J. C., Miyai, K., Keku, T., Sandler, R. S., and Carethers, J. M. (2006) Influence of target gene mutations on survival, stage and histology in sporadic microsatellite unstable colon cancers. Int. J. Cancer 118, 2509-2513
36. Mrózek, A., Petrowsky, H., Sturm, I., Kraus, J., Hermann, S., Hauptmann, S., Lorenz, M., Dörken, B., and Daniel, P. T. (2003) Combined p53/Bax mutation results in extremely poor prognosis in gastric carcinoma with low microsatellite instability. Cell Death Differ. 10, 461-467 (Pubitemid 36626358)
37. Goping, I. S., Gross, A., Lavoie, J. N., Nguyen, M., Jemmerson, R., Roth, K., Korsmeyer, S. J., and Shore, G. C. (1998) Regulated targeting of BAX to mitochondria. J. Cell Biol. 143, 207-215 (Pubitemid 28480529)
38. Sun, X., Chen, C., Vessella, R. L., and Dong, J. T. (2006) Microsatellite instability and mismatch repair target gene mutations in cell lines and xenografts of prostate cancer. Prostate 66, 660-666
39. Köhler, T., Schill, C., Deininger, M. W., Krahl, R., Borchert, S., Hasenclever, D., Leiblein, S., Wagner, O., and Niederwieser, D. (2002) High Bad and Bax mRNA expression correlate with negative outcome in acute myeloid leukemia (AML). Leukemia 16, 22-29 (Pubitemid 34105595)
40. Lalier, L., Cartron, P. F., Juin, P., Nedelkina, S., Manon, S., Bechinger, B., and Vallette, F. M. (2007) Bax activation and mitochondrial insertion during apoptosis. Apoptosis 12, 887-896 (Pubitemid 46653297)
41. Xiang, J., Chao, D. T., and Korsmeyer, S. J. (1996) BAX-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases. Proc. Natl. Acad. Sci. U.S.A. 93, 14559-14563
42. Scorrano, L., and Korsmeyer, S. J. (2003) Mechanisms of cytochrome c release by proapoptotic BCL-2 family members. Biochem. Biophys. Res. Commun. 304, 437-444 (Pubitemid 36506515)
43. Yin, X. M., Oltvai, Z. N., and Korsmeyer, S. J. (1995) Heterodimerization with Bax is required for Bcl-2 to repress cell death. Curr. Top. Microbiol. Immunol. 194, 331-338 (Pubitemid 24369472)
44. Wolter, K. G., Hsu, Y. T., Smith, C. L., Nechushtan, A., Xi, X. G., and Youle, R. J. (1997) Movement of Bax from the cytosol to mitochondria during apoptosis. J. Cell Biol. 139, 1281-1292 (Pubitemid 27523214)
45. Baldwin, E. L., and Osheroff, N. (2005) Etoposide, topoisomerase II and cancer. Curr. Med. Chem. Anticancer Agents 5, 363-372 (Pubitemid 40974810)
46. Chlopkiewicz, B. (2002) Evaluation of adriamycin induced DNA damage and repair in human and animal cells. Acta Pol. Pharm. 59, 115-120
47. Cartron, P. F., Arokium, H., Oliver, L., Meflah, K., Manon, S., and Vallette, F. M. (2005) Distinct domains control the addressing and the insertion of Bax into mitochondria. J. Biol. Chem. 280, 10587-10598 (Pubitemid 40395920)
48. Gavathiotis, E., Suzuki, M., Davis, M. L., Pitter, K., Bird, G. H., Katz, S. G., Tu, H. C., Kim, H., Cheng, E. H., Tjandra, N., and Walensky, L. D. (2008) BAX activation is initiated at a novel interaction site. Nature 455, 1076-1081
49. Sani, M. A., Dufourc, E. J., and Gröbner, G. (2009) How does the Bax-α1 targeting sequence interact with mitochondrial membranes? The role of cardiolipin. Biochim. Biophys. Acta 1788, 623-631
50. Liu, F. T., Agrawal, S. G., Gribben, J. G., Ye, H., Du, M. Q., Newland, A. C., and Jia, L. (2008) Bortezomib blocks Bax degradation in malignant B cells during treatment with TRAIL. Blood 111, 2797-2805
51. Yeh, E. T., Tong, A. T., Lenihan, D. J., Yusuf, S. W., Swafford, J., Champion, C., Durand, J. B., Gibbs, H., Zafarmand, A. A., and Ewer, M. S. (2004) Cardiovascular complications of cancer therapy. Diagnosis, pathogenesis, and management. Circulation 109, 3122-3131
52. Hofland, K. F., Thougaard, A. V., Sehested, M., and Jensen, P. B. (2005) Dexrazoxane protects against myelosuppression from the DNA cleavage-enhancing drugs etoposide and daunorubicin but not doxorubicin. Clin. Cancer Res. 11, 3915-3924 (Pubitemid 40685613)
53. Nithipongvanitch, R., Ittarat, W., Velez, J. M., Zhao, R., St Clair, D. K., and Oberley, T. D. (2007) Evidence for p53 as guardian of the cardiomyocyte mitochondrial genome following acute adriamycin treatment. J. Histochem. Cytochem. 55, 629-639 (Pubitemid 46791945)